Related Experiment Video
Updated: Sep 21, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins
James E Egan1, Amy B Hall, Bogdan A Yatsula
1Department of Molecular Genetics and Microbiology and Graduate Program in Molecular Pharmacology, State University of New York, Stony Brook, NY 11794-5222, USA.
Abstract:
Signal transduction through epidermal growth factor receptors (EGFRs) is essential for the growth and development of multicellular organisms. A genetic screen for regulators of EGFR signaling has led to the identification of Sprouty, a cell autonomous inhibitor of EGF signaling that is transcriptionally induced by the pathway. However, the molecular mechanisms by which Sprouty exerts its antagonistic effect remain largely unknown. Here we have used transient expression in human cells to investigate the functional properties of human Sprouty (hSpry) proteins. Ectopically expressed full-length hSpry1 and hSpry2 induce the potentiation of EGFR-mediated mitogen-activated protein (MAP) kinase activation. In contrast, truncation mutants of hSpry1 and hSpry2 containing the highly conserved carboxyl-terminal cysteine-rich domain inhibit EGF-induced MAP kinase activation. The potentiating effect of the full-length hSpry2 proteins on EGF signaling is mediated by the amino-terminal domain and results from the sequestration of c-Cbl, which in turn leads to the inhibition of EGFR ubiquitination and degradation. These results indicate that hSpry2 can function both as a negative and positive regulator of EGFR-mediated MAP kinase signaling in a domain-dependent fashion. A dual function of this kind could provide a mechanism for achieving proper balance between the activation and repression of EGFR signaling.
Insights
Sprouty proteins regulate epidermal growth factor receptor (EGFR) signaling. Full-length Sprouty can enhance EGFR activity, while truncated forms inhibit it, revealing a dual regulatory role.
Area of Science:
- Cellular biology
- Molecular mechanisms of signal transduction
Background:
- Epidermal growth factor receptor (EGFR) signaling is crucial for multicellular organism development.
- Sprouty proteins are identified as inhibitors of EGFR signaling, but their precise mechanisms are unclear.
Purpose of the Study:
- To investigate the functional properties of human Sprouty (hSpry) proteins in EGFR signaling.
- To elucidate the molecular mechanisms underlying Sprouty's role in regulating EGFR-mediated pathways.
Main Methods:
- Transient expression of full-length and truncated human Sprouty proteins (hSpry1, hSpry2) in human cells.
- Analysis of EGFR-mediated mitogen-activated protein (MAP) kinase activation.
- Investigation of protein interactions, including c-Cbl sequestration and EGFR ubiquitination/degradation.
Main Results:
- Full-length hSpry1 and hSpry2 potentiated EGFR-mediated MAP kinase activation.
- Truncation mutants, particularly those with the conserved carboxyl-terminal cysteine-rich domain, inhibited EGF-induced MAP kinase activation.
- Full-length hSpry2's potentiation involved its amino-terminal domain, sequestering c-Cbl and reducing EGFR ubiquitination and degradation.
Conclusions:
- Human Sprouty proteins exhibit domain-dependent dual functions, acting as both negative and positive regulators of EGFR-mediated MAP kinase signaling.
- This dual regulation by hSpry2 may provide a mechanism for balancing EGFR pathway activation and repression.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Renewal of Skin Epidermal Stem Cells

